Existential Intelligence

Partnerships

Combine specialized oncology intelligence with the infrastructure required to validate, scale, and commercialize it.

Engagements can include strategic equity investment, sponsored R&D, milestone-based programs, data and specimen collaboration, external validation, licensing, royalties, revenue sharing, clinical-trial services, and geographic or indication-specific commercialization.

Strategic Investment

Equity relationships that help expand the company platform, team, intellectual property, and commercial readiness.

Sponsored Development

Defined research and development programs funded through milestone-based or cost-reimbursement structures.

Product Commercialization

Product-specific licensing, royalties, revenue sharing, or joint commercialization.

Data and Validation Collaboration

Structured access to datasets, specimens, clinical expertise, external validation sites, or longitudinal cohorts.

Existential Intelligence background IPPartner background IPContributed dataProject-generated IPProduct-specific commercial rights

Partnership inquiry

Start a structured collaboration discussion.

Do not submit protected health information, patient-identifiable data, or confidential study data through this form.